AIBioTech has provided automated DNA sequencing services on a commercial basis since 1992. We are pleased to announce that we have expanded and modernized our capabilities and now offer state-of-the-art next generation sequencing (NGS) analysis on the Roche 454 platform. We have extensive experience and can provide custom project design and support. AIBiotech is CAP/CLIA certified and our sequencing services meet all of the requirements needed for CLIA and/or GLP regulatory compliance. We routinely are involved in biodefense and forensic related investigations requiring NGS. Let AIBioTech help you successfully complete your NGS project.
AIBioTech is a leading provider of comprehensive DNA sequencing services, genome analysis and bioinformatics, as well as comprehensive molecular biology services. Comprehensive sequencing service includes both Sanger and next generation sequencing capabilities. The service provides options for CAP, CLIA, GLP or R&D level documented reports. AIBioTech provides the following sequencing services including:
Next generation sequencing (NGS) by 454 FLX and GS JR systems with titanium chemistry:
- Roche 454 instrumentation
- Metagenomic analysis
- De Novo genome analysis (bacterial and viral)
- 400 base sequence read length
- Throughput > 600 million bases per run
- Deep comprehensive sequencing of samples (100-1000s X)
- Tumor sample analysis
- Microbial ID
- Methylation studies
- Exon sequencing
- Custom projects
In addition to NGS we also offer more traditional sequencing technology:
- Sanger sequencing via AB Big Dye chemistry
- AB 3100, 3130, and 3500 instrumentation
- Single reaction sequencing, R&D
- Comprehensive 4x coverage for GLP, FDA submission
- Genomics
- Bioinformatics
- Nucleic acid extraction, various sample types
- Plasmid prep (variety of scales)
- Primer walking
- PCR sequencing
- Shotgun sequencing
- SNP verification re-sequencing
- Viral DNA/RNA sequencing
- Biosafety testing